Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -23.96M
March 31, 2026 52.89M
December 31, 2025 6.41M
September 30, 2025 56.49M
June 30, 2025 52.62M
March 31, 2025 33.12M
December 31, 2024 35.75M
September 30, 2024 10.03M
June 30, 2024 30.23M
March 31, 2024 3.691M
December 31, 2023 19.83M
September 30, 2023 25.79M
June 30, 2023 30.47M
March 31, 2023 7.217M
December 31, 2022 6.297M
September 30, 2022 -9.507M
June 30, 2022 18.17M
March 31, 2022 -36.42M
December 31, 2021 0.934M
September 30, 2021 -5.882M
June 30, 2021 18.72M
March 31, 2021 8.262M
December 31, 2020 15.20M
September 30, 2020 23.97M
June 30, 2020 141.08M
Date Value
March 31, 2020 1.126M
December 31, 2019 18.49M
September 30, 2019 30.03M
June 30, 2019 19.46M
March 31, 2019 5.727M
December 31, 2018 14.30M
September 30, 2018 20.44M
June 30, 2018 27.71M
March 31, 2018 6.206M
December 31, 2017 15.45M
September 30, 2017 23.04M
June 30, 2017 18.68M
March 31, 2017 4.945M
December 31, 2016 13.97M
September 30, 2016 4.014M
June 30, 2016 -0.517M
March 31, 2016 10.82M
December 31, 2015 -8.335M
September 30, 2015 10.44M
June 30, 2015 11.03M
March 31, 2015 11.80M
December 31, 2014 -4.856M
September 30, 2014 21.60M
June 30, 2014 -0.223M
March 31, 2014 5.877M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
The Ensign Group, Inc. 119.13M
Regional Health Properties, Inc. 0.889M
Chemed Corp. 69.29M
Oncologix Tech, Inc. --
InnovAge Holding Corp. 17.02M